Delivery Order SPE2DR25D2205-SPE2DR26F1F80
- Not listed
- The Defense Logistics Agency awarded a $1,301.28 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for Belbuca 450 mcg film, with an ultimate completion date of September 19, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. Belbuca is a buccal film formulation used for pain management in opioid-tolerant patients. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Belbuca 300 mcg film (60-count), with a ceiling value of $1,075.23. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a $1,455.48 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 microgram film (60 count) on September 19, 2025, with completion targeted for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...
- The Defense Logistics Agency awarded a $2,429.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Belbuca 600 mcg film (60 count). This is a non-set-aside contract with an ultimate completion date of October 21, 2025, and performance will take place at the contractor's facility in Conshohocken, Pennsylvania. Belbuca is a buccal film formulation of buprenorphine used for pain management, reflecting the Defense Logistics Agency's ongoing need to...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Belbuca 600 microgram films (60 count). This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,683.50 with firm fixed pricing and an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,635.46 by the Defense Logistics Agency on June 13, 2025, with an ultimate completion date of June 16, 2025. The contract, which carries no set-aside designation, calls for the delivery of Belbuca 300 microgram film (60 count), a buccal film formulation used for pain management. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,027.72 to AmerisourceBergen Drug Corp for BELBUCA 150 MCG film (60 units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitive award utilized firm fixed pricing and required no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,301.11 delivery order to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60 count) under a firm fixed price contract. The order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $4,192.70 to AmerisourceBergen Drug Corp for BELBUCA 750 mcg Film, 60 count units, with delivery to the vendor's Conshohocken, Pennsylvania location. This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of April 25, 2025. BELBUCA is a transmucosal buccal film formulation used for opioid pain management in opioid-tolerant patients, representing a specialized...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1F80Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,045.41 to AmerisourceBergen Drug Corp for 60 units of Belbuca 600 microgram film on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical supply vehicle running through December 2026. Belbuca is a specialty opioid medication used for pain management in opioid-tolerant patients. AmerisourceBergen's role as a prime pharmaceutical vendor through the DLA Medical Supply Chain enables the company to distribute a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The company's status as a major pharmaceutical distributor with an extensive portfolio of federal medical contracts reflects its established capability to meet Department of Defense procurement requirements through competitive award processes and to efficiently deliver controlled pharmaceutical products to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/5/25 |